Buchang Pharmaceuticals: The controlling subsidiary Buchang Changyan's shareholder Ding Li intends to transfer her 1% equity stake in Buchang Changyan to Wang Minxi at a price of 13,700 yuan.

2026-04-10 14:30:23

Long March Pharmaceutical Announcement, the company’s controlling subsidiary Long March Changyan’s shareholder Ding Li intends to transfer her 1% equity stake in Long March Changyan to Wang Minxi at a price of 13,700 yuan. After the transaction is completed, the company’s ownership stake in Long March Changyan remains unchanged at 90%. As of February 28, 2026, Long March Changyan’s net assets are 1.3686 million yuan (unaudited).

Ver originales

Esta página puede contener contenido de terceros, que se proporciona únicamente con fines informativos (sin garantías ni declaraciones) y no debe considerarse como un respaldo por parte de Gate a las opiniones expresadas ni como asesoramiento financiero o profesional. Consulte el Descargo de responsabilidad para obtener más detalles.